img

Global Celiac Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Celiac Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjögren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease.
Celiac Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Celiac Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Men and Women are the major drivers for the industry.
North America dominates the global market for celiac drugs due to rising incidence of celiac disease and lack of treatment options in the region. Asia is expected to show high growth rates in the next five years in global celiac drugs market, with China and India being the fastest growing markets in the Asia-Pacific region. The key driving forces for the celiac drugs market in developing countries are the large pool of patients, increasing awareness about the disease, and rising government funding in the region.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Celiac Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis
Segment by Type
First Line Of Treatment
Second Line Of Treatment

Segment by Application


Men
Women
Children

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Celiac Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Celiac Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Celiac Drugs industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Celiac Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Celiac Drugs introduction, etc. Celiac Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Celiac Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Celiac Drugs Market Overview
1.1 Celiac Drugs Product Overview
1.2 Celiac Drugs Market Segment by Type
1.2.1 First Line Of Treatment
1.2.2 Second Line Of Treatment
1.3 Global Celiac Drugs Market Size by Type
1.3.1 Global Celiac Drugs Market Size Overview by Type (2024-2034)
1.3.2 Global Celiac Drugs Historic Market Size Review by Type (2024-2024)
1.3.3 Global Celiac Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Celiac Drugs Sales Breakdown by Type (2024-2024)
1.4.2 Europe Celiac Drugs Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Celiac Drugs Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Celiac Drugs Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Celiac Drugs Sales Breakdown by Type (2024-2024)
2 Global Celiac Drugs Market Competition by Company
2.1 Global Top Players by Celiac Drugs Sales (2024-2024)
2.2 Global Top Players by Celiac Drugs Revenue (2024-2024)
2.3 Global Top Players by Celiac Drugs Price (2024-2024)
2.4 Global Top Manufacturers Celiac Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Celiac Drugs Market Competitive Situation and Trends
2.5.1 Celiac Drugs Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Celiac Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Celiac Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Celiac Drugs Market
2.8 Key Manufacturers Celiac Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Celiac Drugs Status and Outlook by Region
3.1 Global Celiac Drugs Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Celiac Drugs Historic Market Size by Region
3.2.1 Global Celiac Drugs Sales in Volume by Region (2024-2024)
3.2.2 Global Celiac Drugs Sales in Value by Region (2024-2024)
3.2.3 Global Celiac Drugs Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Celiac Drugs Forecasted Market Size by Region
3.3.1 Global Celiac Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Celiac Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Celiac Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Celiac Drugs by Application
4.1 Celiac Drugs Market Segment by Application
4.1.1 Men
4.1.2 Women
4.1.3 Children
4.2 Global Celiac Drugs Market Size by Application
4.2.1 Global Celiac Drugs Market Size Overview by Application (2024-2034)
4.2.2 Global Celiac Drugs Historic Market Size Review by Application (2024-2024)
4.2.3 Global Celiac Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Celiac Drugs Sales Breakdown by Application (2024-2024)
4.3.2 Europe Celiac Drugs Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Celiac Drugs Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Celiac Drugs Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Celiac Drugs Sales Breakdown by Application (2024-2024)
5 North America Celiac Drugs by Country
5.1 North America Celiac Drugs Historic Market Size by Country
5.1.1 North America Celiac Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Celiac Drugs Sales in Volume by Country (2024-2024)
5.1.3 North America Celiac Drugs Sales in Value by Country (2024-2024)
5.2 North America Celiac Drugs Forecasted Market Size by Country
5.2.1 North America Celiac Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Celiac Drugs Sales in Value by Country (2024-2034)
6 Europe Celiac Drugs by Country
6.1 Europe Celiac Drugs Historic Market Size by Country
6.1.1 Europe Celiac Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Celiac Drugs Sales in Volume by Country (2024-2024)
6.1.3 Europe Celiac Drugs Sales in Value by Country (2024-2024)
6.2 Europe Celiac Drugs Forecasted Market Size by Country
6.2.1 Europe Celiac Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Celiac Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Celiac Drugs by Region
7.1 Asia-Pacific Celiac Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Celiac Drugs Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Celiac Drugs Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Celiac Drugs Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Celiac Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Celiac Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Celiac Drugs Sales in Value by Region (2024-2034)
8 Latin America Celiac Drugs by Country
8.1 Latin America Celiac Drugs Historic Market Size by Country
8.1.1 Latin America Celiac Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Celiac Drugs Sales in Volume by Country (2024-2024)
8.1.3 Latin America Celiac Drugs Sales in Value by Country (2024-2024)
8.2 Latin America Celiac Drugs Forecasted Market Size by Country
8.2.1 Latin America Celiac Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Celiac Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Celiac Drugs by Country
9.1 Middle East and Africa Celiac Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Celiac Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Celiac Drugs Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Celiac Drugs Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Celiac Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Celiac Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Celiac Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 ADMA Biologics
10.1.1 ADMA Biologics Company Information
10.1.2 ADMA Biologics Introduction and Business Overview
10.1.3 ADMA Biologics Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.1.4 ADMA Biologics Celiac Drugs Products Offered
10.1.5 ADMA Biologics Recent Development
10.2 Amgen
10.2.1 Amgen Company Information
10.2.2 Amgen Introduction and Business Overview
10.2.3 Amgen Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Amgen Celiac Drugs Products Offered
10.2.5 Amgen Recent Development
10.3 Anthera Pharmaceuticals
10.3.1 Anthera Pharmaceuticals Company Information
10.3.2 Anthera Pharmaceuticals Introduction and Business Overview
10.3.3 Anthera Pharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Anthera Pharmaceuticals Celiac Drugs Products Offered
10.3.5 Anthera Pharmaceuticals Recent Development
10.4 Bayer
10.4.1 Bayer Company Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Bayer Celiac Drugs Products Offered
10.4.5 Bayer Recent Development
10.5 Biogen
10.5.1 Biogen Company Information
10.5.2 Biogen Introduction and Business Overview
10.5.3 Biogen Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Biogen Celiac Drugs Products Offered
10.5.5 Biogen Recent Development
10.6 BioLineRx
10.6.1 BioLineRx Company Information
10.6.2 BioLineRx Introduction and Business Overview
10.6.3 BioLineRx Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.6.4 BioLineRx Celiac Drugs Products Offered
10.6.5 BioLineRx Recent Development
10.7 Biotest
10.7.1 Biotest Company Information
10.7.2 Biotest Introduction and Business Overview
10.7.3 Biotest Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Biotest Celiac Drugs Products Offered
10.7.5 Biotest Recent Development
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Company Information
10.8.2 Bristol-Myers Squibb Introduction and Business Overview
10.8.3 Bristol-Myers Squibb Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Bristol-Myers Squibb Celiac Drugs Products Offered
10.8.5 Bristol-Myers Squibb Recent Development
10.9 Celgene
10.9.1 Celgene Company Information
10.9.2 Celgene Introduction and Business Overview
10.9.3 Celgene Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Celgene Celiac Drugs Products Offered
10.9.5 Celgene Recent Development
10.10 Celimmune
10.10.1 Celimmune Company Information
10.10.2 Celimmune Introduction and Business Overview
10.10.3 Celimmune Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Celimmune Celiac Drugs Products Offered
10.10.5 Celimmune Recent Development
10.11 F Hoffmann-La Roche
10.11.1 F Hoffmann-La Roche Company Information
10.11.2 F Hoffmann-La Roche Introduction and Business Overview
10.11.3 F Hoffmann-La Roche Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.11.4 F Hoffmann-La Roche Celiac Drugs Products Offered
10.11.5 F Hoffmann-La Roche Recent Development
10.12 ImmunogenX
10.12.1 ImmunogenX Company Information
10.12.2 ImmunogenX Introduction and Business Overview
10.12.3 ImmunogenX Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.12.4 ImmunogenX Celiac Drugs Products Offered
10.12.5 ImmunogenX Recent Development
10.13 Immunomedics
10.13.1 Immunomedics Company Information
10.13.2 Immunomedics Introduction and Business Overview
10.13.3 Immunomedics Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Immunomedics Celiac Drugs Products Offered
10.13.5 Immunomedics Recent Development
10.14 ImmusanT
10.14.1 ImmusanT Company Information
10.14.2 ImmusanT Introduction and Business Overview
10.14.3 ImmusanT Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.14.4 ImmusanT Celiac Drugs Products Offered
10.14.5 ImmusanT Recent Development
10.15 Innovate Biopharmaceuticals
10.15.1 Innovate Biopharmaceuticals Company Information
10.15.2 Innovate Biopharmaceuticals Introduction and Business Overview
10.15.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Innovate Biopharmaceuticals Celiac Drugs Products Offered
10.15.5 Innovate Biopharmaceuticals Recent Development
10.16 Johnson & Johnson
10.16.1 Johnson & Johnson Company Information
10.16.2 Johnson & Johnson Introduction and Business Overview
10.16.3 Johnson & Johnson Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Johnson & Johnson Celiac Drugs Products Offered
10.16.5 Johnson & Johnson Recent Development
10.17 Kedrion Biopharma
10.17.1 Kedrion Biopharma Company Information
10.17.2 Kedrion Biopharma Introduction and Business Overview
10.17.3 Kedrion Biopharma Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Kedrion Biopharma Celiac Drugs Products Offered
10.17.5 Kedrion Biopharma Recent Development
10.18 LFB Group
10.18.1 LFB Group Company Information
10.18.2 LFB Group Introduction and Business Overview
10.18.3 LFB Group Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.18.4 LFB Group Celiac Drugs Products Offered
10.18.5 LFB Group Recent Development
10.19 Merck
10.19.1 Merck Company Information
10.19.2 Merck Introduction and Business Overview
10.19.3 Merck Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Merck Celiac Drugs Products Offered
10.19.5 Merck Recent Development
10.20 Novartis
10.20.1 Novartis Company Information
10.20.2 Novartis Introduction and Business Overview
10.20.3 Novartis Celiac Drugs Sales, Revenue and Gross Margin (2024-2024)
10.20.4 Novartis Celiac Drugs Products Offered
10.20.5 Novartis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Celiac Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Celiac Drugs Industrial Chain Analysis
11.4 Celiac Drugs Market Dynamics
11.4.1 Celiac Drugs Industry Trends
11.4.2 Celiac Drugs Market Drivers
11.4.3 Celiac Drugs Market Challenges
11.4.4 Celiac Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Celiac Drugs Distributors
12.3 Celiac Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of First Line Of Treatment
Table 2. Major Company of Second Line Of Treatment
Table 3. Global Celiac Drugs Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Celiac Drugs Sales by Type (2024-2024) & (K Units)
Table 5. Global Celiac Drugs Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Celiac Drugs Sales by Type (2024-2024) & (US& Million)
Table 7. Global Celiac Drugs Market Share in Value by Type (2024-2024)
Table 8. Global Celiac Drugs Price by Type (2024-2024) & (USD/Unit)
Table 9. Global Celiac Drugs Sales by Type (2024-2034) & (K Units)
Table 10. Global Celiac Drugs Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Celiac Drugs Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Celiac Drugs Sales Market Share in Value by Type (2024-2034)
Table 13. Global Celiac Drugs Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Celiac Drugs Sales by Type (2024-2024) & (K Units)
Table 15. North America Celiac Drugs Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Celiac Drugs Sales (K Units) by Type (2024-2024)
Table 17. Europe Celiac Drugs Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Celiac Drugs Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Celiac Drugs Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Celiac Drugs Sales (K Units) by Type (2024-2024)
Table 21. Latin America Celiac Drugs Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Celiac Drugs Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Celiac Drugs Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Celiac Drugs Sales by Company (2024-2024) & (K Units)
Table 25. Global Celiac Drugs Sales Share by Company (2024-2024)
Table 26. Global Celiac Drugs Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Celiac Drugs Revenue Share by Company (2024-2024)
Table 28. Global Market Celiac Drugs Price by Company (2024-2024) & (USD/Unit)
Table 29. Global Celiac Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Celiac Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Celiac Drugs as of 2022)
Table 32. Date of Key Manufacturers Enter into Celiac Drugs Market
Table 33. Key Manufacturers Celiac Drugs Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Celiac Drugs Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Celiac Drugs Sales by Region (2024-2024) & (K Units)
Table 37. Global Celiac Drugs Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Celiac Drugs Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Celiac Drugs Sales Market Share in Value by Region (2024-2024)
Table 40. Global Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 41. Global Celiac Drugs Sales by Region (2024-2034) & (K Units)
Table 42. Global Celiac Drugs Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Celiac Drugs Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Celiac Drugs Sales Market Share in Value by Region (2024-2034)
Table 45. Global Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Celiac Drugs Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Celiac Drugs Sales by Application (2024-2024) & (K Units)
Table 48. Global Celiac Drugs Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Celiac Drugs Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Celiac Drugs Sales Market Share in Value by Application (2024-2024)
Table 51. Global Celiac Drugs Price by Application (2024-2024) & (USD/Unit)
Table 52. Global Celiac Drugs Sales by Application (2024-2034) & (K Units)
Table 53. Global Celiac Drugs Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Celiac Drugs Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Celiac Drugs Sales Market Share in Value by Application (2024-2034)
Table 56. Global Celiac Drugs Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Celiac Drugs Sales by Application (2024-2024) (K Units)
Table 58. North America Celiac Drugs Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Celiac Drugs Sales by Application (2024-2024) (K Units)
Table 60. Europe Celiac Drugs Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Celiac Drugs Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Celiac Drugs Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Celiac Drugs Sales by Application (2024-2024) (K Units)
Table 64. Latin America Celiac Drugs Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Celiac Drugs Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Celiac Drugs Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Celiac Drugs Sales by Country (2024-2024) & (K Units)
Table 68. North America Celiac Drugs Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Celiac Drugs Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Celiac Drugs Sales Market Share in Value by Country (2024-2024)
Table 71. North America Celiac Drugs Sales by Country (2024-2034) & (K Units)
Table 72. North America Celiac Drugs Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Celiac Drugs Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Celiac Drugs Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Celiac Drugs Sales by Country (2024-2024) & (K Units)
Table 76. Europe Celiac Drugs Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Celiac Drugs Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Celiac Drugs Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Celiac Drugs Sales by Country (2024-2034) & (K Units)
Table 80. Europe Celiac Drugs Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Celiac Drugs Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Celiac Drugs Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Celiac Drugs Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Celiac Drugs Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Celiac Drugs Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Celiac Drugs Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Celiac Drugs Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Celiac Drugs Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Celiac Drugs Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Celiac Drugs Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Celiac Drugs Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Celiac Drugs Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Celiac Drugs Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Celiac Drugs Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Celiac Drugs Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Celiac Drugs Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Celiac Drugs Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Celiac Drugs Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Celiac Drugs Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Celiac Drugs Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Celiac Drugs Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Celiac Drugs Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Celiac Drugs Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Celiac Drugs Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Celiac Drugs Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Celiac Drugs Sales Market Share in Value by Country (2024-2034)
Table 107. ADMA Biologics Company Information
Table 108. ADMA Biologics Introduction and Business Overview
Table 109. ADMA Biologics Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 110. ADMA Biologics Celiac Drugs Product
Table 111. ADMA Biologics Recent Development
Table 112. Amgen Company Information
Table 113. Amgen Introduction and Business Overview
Table 114. Amgen Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 115. Amgen Celiac Drugs Product
Table 116. Amgen Recent Development
Table 117. Anthera Pharmaceuticals Company Information
Table 118. Anthera Pharmaceuticals Introduction and Business Overview
Table 119. Anthera Pharmaceuticals Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 120. Anthera Pharmaceuticals Celiac Drugs Product
Table 121. Anthera Pharmaceuticals Recent Development
Table 122. Bayer Company Information
Table 123. Bayer Introduction and Business Overview
Table 124. Bayer Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 125. Bayer Celiac Drugs Product
Table 126. Bayer Recent Development
Table 127. Biogen Company Information
Table 128. Biogen Introduction and Business Overview
Table 129. Biogen Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 130. Biogen Celiac Drugs Product
Table 131. Biogen Recent Development
Table 132. BioLineRx Company Information
Table 133. BioLineRx Introduction and Business Overview
Table 134. BioLineRx Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 135. BioLineRx Celiac Drugs Product
Table 136. BioLineRx Recent Development
Table 137. Biotest Company Information
Table 138. Biotest Introduction and Business Overview
Table 139. Biotest Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 140. Biotest Celiac Drugs Product
Table 141. Biotest Recent Development
Table 142. Bristol-Myers Squibb Company Information
Table 143. Bristol-Myers Squibb Introduction and Business Overview
Table 144. Bristol-Myers Squibb Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 145. Bristol-Myers Squibb Celiac Drugs Product
Table 146. Bristol-Myers Squibb Recent Development
Table 147. Celgene Company Information
Table 148. Celgene Introduction and Business Overview
Table 149. Celgene Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 150. Celgene Celiac Drugs Product
Table 151. Celgene Recent Development
Table 152. Celimmune Company Information
Table 153. Celimmune Introduction and Business Overview
Table 154. Celimmune Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 155. Celimmune Celiac Drugs Product
Table 156. Celimmune Recent Development
Table 157. F Hoffmann-La Roche Company Information
Table 158. F Hoffmann-La Roche Introduction and Business Overview
Table 159. F Hoffmann-La Roche Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 160. F Hoffmann-La Roche Celiac Drugs Product
Table 161. F Hoffmann-La Roche Recent Development
Table 162. ImmunogenX Company Information
Table 163. ImmunogenX Introduction and Business Overview
Table 164. ImmunogenX Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 165. ImmunogenX Celiac Drugs Product
Table 166. ImmunogenX Recent Development
Table 167. Immunomedics Company Information
Table 168. Immunomedics Introduction and Business Overview
Table 169. Immunomedics Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 170. Immunomedics Celiac Drugs Product
Table 171. Immunomedics Recent Development
Table 172. ImmusanT Company Information
Table 173. ImmusanT Introduction and Business Overview
Table 174. ImmusanT Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 175. ImmusanT Celiac Drugs Product
Table 176. ImmusanT Recent Development
Table 177. Innovate Biopharmaceuticals Company Information
Table 178. Innovate Biopharmaceuticals Introduction and Business Overview
Table 179. Innovate Biopharmaceuticals Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 180. Innovate Biopharmaceuticals Celiac Drugs Product
Table 181. Innovate Biopharmaceuticals Recent Development
Table 182. Johnson & Johnson Company Information
Table 183. Johnson & Johnson Introduction and Business Overview
Table 184. Johnson & Johnson Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 185. Johnson & Johnson Celiac Drugs Product
Table 186. Johnson & Johnson Recent Development
Table 187. Kedrion Biopharma Company Information
Table 188. Kedrion Biopharma Introduction and Business Overview
Table 189. Kedrion Biopharma Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 190. Kedrion Biopharma Celiac Drugs Product
Table 191. Kedrion Biopharma Recent Development
Table 192. LFB Group Company Information
Table 193. LFB Group Introduction and Business Overview
Table 194. LFB Group Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 195. LFB Group Celiac Drugs Product
Table 196. LFB Group Recent Development
Table 197. Merck Company Information
Table 198. Merck Introduction and Business Overview
Table 199. Merck Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 200. Merck Celiac Drugs Product
Table 201. Merck Recent Development
Table 202. Novartis Company Information
Table 203. Novartis Introduction and Business Overview
Table 204. Novartis Celiac Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 205. Novartis Celiac Drugs Product
Table 206. Novartis Recent Development
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. Celiac Drugs Market Trends
Table 210. Celiac Drugs Market Drivers
Table 211. Celiac Drugs Market Challenges
Table 212. Celiac Drugs Market Restraints
Table 213. Celiac Drugs Distributors List
Table 214. Celiac Drugs Downstream Customers
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Celiac Drugs Product Picture
Figure 2. Global Celiac Drugs Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Celiac Drugs Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Celiac Drugs Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of First Line Of Treatment
Figure 6. Global First Line Of Treatment Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Second Line Of Treatment
Figure 8. Global Second Line Of Treatment Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Celiac Drugs Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Celiac Drugs Sales Market Share by Type in 2022 & 2034
Figure 11. North America Celiac Drugs Sales Market Share in Volume by Type in 2022
Figure 12. North America Celiac Drugs Sales Market Share in Value by Type in 2022
Figure 13. Europe Celiac Drugs Sales Market Share in Volume by Type in 2022
Figure 14. Europe Celiac Drugs Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Celiac Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Celiac Drugs Sales Market Share in Value by Type in 2022
Figure 17. Latin America Celiac Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Celiac Drugs Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Celiac Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Celiac Drugs Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Celiac Drugs Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Celiac Drugs Revenue in 2022
Figure 23. Celiac Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Men
Figure 25. Global Men Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Women
Figure 27. Global Women Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Children
Figure 29. Global Children Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Celiac Drugs Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Celiac Drugs Sales Market Share by Application in 2022 & 2034
Figure 32. North America Celiac Drugs Sales Market Share in Volume by Application in 2022
Figure 33. North America Celiac Drugs Sales Market Share in Value by Application in 2022
Figure 34. Europe Celiac Drugs Sales Market Share in Volume by Application in 2022
Figure 35. Europe Celiac Drugs Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Celiac Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Celiac Drugs Sales Market Share in Value by Application in 2022
Figure 38. Latin America Celiac Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Celiac Drugs Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Celiac Drugs Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Celiac Drugs Manufacturing Cost Structure
Figure 43. Celiac Drugs Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed